Financials
- Market Capitalization 483.27 M
- Employee 3 595
- Founded 2013
- CEO Irwin D.Simon
- Website www.tilray.com
- Headquarter New York, United States
- FIGI BBG00L7XTP60
- Industry Case Farmaceutiche - Specialistico e Generico
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-5.04
Rapporto prezzo/fatturato
0.67
Related tickers
| # | Nome | Prezzo | 24h % | 7d % | 1M % | 1Y % | Valore di Mercato | Ultimi 7 Giorni | |
|---|---|---|---|---|---|---|---|---|---|
| 2746 | AQST Aquestive Therapeutics, Inc. - Common Stock | 4.67 USD | -2.91% | +1.97% | -3.11% | -32.90% | 586.14 M USD | ||
| 2848 | EOLS Evolus, Inc. - Common Stock | 7.51 USD | -3.10% | +1.90% | -4.70% | +17.71% | 496.04 M USD | ||
| 2873 | EVO Evotec SE - American Depositary Shares each representing 1/2 of | 1.35 USD | -1.46% | -15.63% | -16.67% | -68.38% | 480.00 M USD | ||
| 2928 | KMDA Kamada Ltd. - Ordinary Shares | 7.69 USD | -1.91% | -2.90% | -5.88% | +14.95% | 443.61 M USD |